18 August 2021 : Clinical Research
Effects of Doxofylline Combined with Ceftazidime on Clinical Efficacy, Drug Safety, and Prognosis in Patients with Chronic Obstructive Pulmonary Disease Complicated with Infection
Ying WangEFGDOI: 10.12659/MSM.930494
Med Sci Monit 2021; 27:e930494
Table 4 Comparison of patients’ quality-of-life scores.
| Group | Case | Physiological function | Social function | Role restriction | Overall health |
|---|---|---|---|---|---|
| Observation group | 225 | 76.10±8.70* | 79.59±10.49* | 79.99±11.72* | 84.23±11.89* |
| Control group | 225 | 63.28±7.89 | 63.59±9.37 | 65.19±11.37 | 65.87±9.86 |
| Blank group | 50 | 77.19±8.21 | 81.58±11.27 | 82.18±12.29 | 85.28±13.94 |
| value | 152.7 | 163.7 | 106.5 | 168.2 | |
| value | <0.001 | <0.001 | <0.001 | <0.001 | |
| * Represented compared with Control group P # represented compared with Blank group, P>0.05. | |||||